In clinical practice, AFP is regarded as a specific tumor biomarker for the screening and diagnosis of primary liver cancer, and it plays an important role in judging the degree of malignancy, evaluation of efficacy, detection of recurrence after surgery, liver transplantation, and guidance for clinical medication (6). This evidence concerns the gene AFP and neoplasm.